Do you want to read an article? Please log in or register.
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
Multiple Sclerosis
Related content
Parkinson’s DiseaseDementia
Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study
JAMA Neurol.
Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM
doi: 10.1001/
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
COMMENTED
Multiple Sclerosis
Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden
JAMA Neurol.
Beiki O, Frumento P, Bottai M, Manouchehrinia A, Hillert J
doi: 10.1001/jamaneurol.
Multiple Sclerosis
A three-year longitudinal study of retinal function and structure in patients with multiple sclerosis
Doc Ophthalmol
Hanson JVM, Ng MY, Hayward-Koennecke HK, Schippling S, Reeve KA, Gerth-Kahlert C
doi: 10.1007/s10633-021-09855-7
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
Aging and Cognitive FunctionsMultiple SclerosisDementia
Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study
Lancet.
Chen H, Kwong JC, Copes R, Tu K, Villeneuve PJ, van Donkelaar A, Hystad P, Martin RV, Murray BJ, Jessiman B, Wilton AS, Kopp A, Burnett RT
doi: 10.1016/
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
Multiple Sclerosis
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies
Mult Scler.
Van Wijmeersch B, Singer BA, Boster A, Broadley S, Fernández Ó, Freedman MS, Izquierdo G, Lycke J, Pozzilli C, Sharrack B, Steingo B, Wiendl H, Wray S, Ziemssen T, Chung L, Margolin DH, Thangavelu K, Vermersch P
doi: 10.1177/1352458519881759.
Multiple Sclerosis
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study
Mult Scler.
Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø
doi: 10.1177/1352458519877244.